Trelegy ellipta and Novolin r drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Trelegy ellipta (fluticasone furoate; umeclidinium bromide; vilanterol trifenatate) and Novolin r (insulin recombinant purified human). Common drug interactions include arthralgia among females.

The phase IV clinical study analyzes what interactions people have when they take Trelegy ellipta and Novolin r. It is created by eHealthMe based on reports of 11 people who take the same drugs from the FDA, and is updated regularly.

What is Trelegy ellipta?

Trelegy ellipta has active ingredients of fluticasone furoate; umeclidinium bromide; vilanterol trifenatate. eHealthMe is studying from 28,101 Trelegy ellipta users. Check the latest studies of Trelegy ellipta.

What is Novolin r?

Novolin r has active ingredients of insulin recombinant purified human. It is often used in type 1 diabetes. eHealthMe is studying from 4,568 Novolin r users. Check the latest studies of Novolin r.



On Jul, 14, 2026

11 people who take Trelegy ellipta and Novolin r together, and have interactions are studied.

Trelegy ellipta and Novolin r drug interactions.

What are the common drug interactions of Trelegy Ellipta and Novolin R, by gender? *:

female:

  1. Arthralgia (joint pain)
  2. Headache (pain in head)
  3. Disorientation (disability in which the senses of time, direction, and recognition of people and places)
  4. Ear haemorrhage (bleeding from ear)
  5. Ear infection
  6. Fall
  7. Family stress
  8. Fatigue (feeling of tiredness)
  9. Gastric infection (infection of stomach)
  10. Gastrointestinal infection (infection of stomach and intestine)

male:

n/a

What are the common drug interactions of Trelegy Ellipta and Novolin R, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

  1. Agitation (state of anxiety or nervous excitement)
  2. Arthralgia (joint pain)
  3. Bacteraemia (presence of bacteria in the blood)
  4. Blood pressure decreased
  5. Breath sounds
  6. Cognitive disorder (mental health disorders affects learning, memory, perception, and problem solving)
  7. Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)
  8. Disorientation (disability in which the senses of time, direction, and recognition of people and places)
  9. Ear haemorrhage (bleeding from ear)
  10. Ear infection

60+:

  1. Adverse drug reaction
  2. Arthralgia (joint pain)
  3. Stomatitis (inflammation of mucous membrane of mouth)
  4. Upper-airway cough syndrome
  5. Blister (small pocket of fluid within the upper layers of the skin caused by forceful rubbing (friction), burning, freezing, chemical exposure)
  6. Decreased appetite
  7. Drug hypersensitivity
  8. Dysphagia (a condition in which swallowing is difficult or painful)
  9. Epistaxis (bleed from the nose)
  10. Gait disturbance

What are the existing conditions these people have? *

  1. Blood Glucose Increased: 4 people, 36.36%
  2. High Blood Pressure: 3 people, 27.27%
  3. Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 3 people, 27.27%
  4. Neuropathy Peripheral (surface nerve damage): 3 people, 27.27%
  5. Neuralgia (pain in one or more nerves): 3 people, 27.27%
  6. Cardiac Disorder: 3 people, 27.27%
  7. Hypovitaminosis (any of several diseases caused by deficiency of one or more vitamins): 3 people, 27.27%
  8. Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 3 people, 27.27%
  9. Hypokalemia (low potassium): 3 people, 27.27%
  10. High Blood Cholesterol: 3 people, 27.27%

* Approximation only. Some reports may have incomplete information.

Do you take Trelegy ellipta and Novolin r?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Trelegy ellipta and Novolin r:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Trelegy ellipta:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Novolin r:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Trelegy ellipta and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Novolin r and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on fluticasone furoate; umeclidinium bromide; vilanterol trifenatate and insulin recombinant purified human (the active ingredients of Trelegy ellipta and Novolin r, respectively), and Trelegy ellipta and Novolin r (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: